Contents

Current Pharmaceutical Design, Volume 19 - Number 17

Editorial(Angiotensin II Receptor Research)

, 19(17): 2979 - 2980

Shin-ichiro Miura


DOI: 10.2174/1381612811319170001




Recent Progress in Molecular Mechanisms of Angiotensin II Type 1 and 2 Receptors

, 19(17): 2981 - 2987

Shin-ichiro Miura, Satoshi Imaizumi and Keijiro Saku


DOI: 10.2174/1381612811319170002




Angiotensin II Type 1 and Type 2 Receptor-induced Cell Signaling

, 19(17): 2988 - 2995

Hiroshi Akazawa, Masamichi Yano, Chizuru Yabumoto, Yoko Kudo-Sakamoto and Issei Komuro


DOI: 10.2174/1381612811319170003




Gene Polymorphism of Angiotensin II Type 1 and Type 2 Receptors

, 19(17): 2996 - 3001

Tomohiro Katsuya and Ryuichi Morishita


DOI: 10.2174/1381612811319170004




Class- and Molecule-specific Differential Effects of Angiotensin II Type 1 Receptor Blockers

, 19(17): 3002 - 3008

Satoshi Imaizumi, Shin-ichiro Miura, Eiji Yahiro, Yoshinari Uehara, Issei Komuro and Keijiro Saku


DOI: 10.2174/1381612811319170005




The Pharmacological Effects of Novokinin; a Designed Peptide Agonist of the Angiotensin AT2 Receptor

, 19(17): 3009 - 3012

Masaaki Yoshikawa, Kousaku Ohinata and Yuko Yamada


DOI: 10.2174/1381612811319170006




Regulation of Angiotensin II Receptor Expression

, 19(17): 3013 - 3021

Toshihiro Ichiki


DOI: 10.2174/1381612811319170007




Redox Control of Cardiovascular Homeostasis by Angiotensin II

, 19(17): 3022 - 3032

Caroline Sunggip, Naoyuki Kitajima and Motohiro Nishida


DOI: 10.2174/1381612811319170008




Angiotensin II Blockade and Renal Protection

, 19(17): 3033 - 3042

Hiroyuki Kobori, Hirohito Mori, Tsutomu Masaki and Akira Nishiyama


DOI: 10.2174/1381612811319170009




The Physiology and Pathophysiology of a Novel Angiotensin Receptor-binding Protein ATRAP/Agtrap

, 19(17): 3043 - 3048

Kouichi Tamura, Hiromichi Wakui, Akinobu Maeda, Toru Dejima, Masato Ohsawa, Kengo Azushima, Tomohiko Kanaoka, Sona Haku, Kazushi Uneda, Shin-ichiro Masuda, Koichi Azuma, Atsu-ichiro Shigenaga, Yuichi Koide, Yuko Tsurumi-Ikeya, Miyuki Matsuda, Yoshiyuki Toya, Yasuo Tokita, Akio Yamashita and Satoshi Umemura


DOI: 10.2174/1381612811319170010




Potential Effect of Angiotensin II Receptor Blockade in Adipose Tissue and Bone

, 19(17): 3049 - 3053

Hironori Nakagami, Mariana Kiomy Osako and Ryuichi Morishita


DOI: 10.2174/1381612811319170011




Non-ACE Pathway-induced Angiotensin II Production

, 19(17): 3054 - 3059

Yoshinari Uehara, Shin-ichiro Miura, Eiji Yahiro and Keijiro Saku


DOI: 10.2174/1381612811319170012




Angiotensin (1-7) and other Angiotensin Peptides

, 19(17): 3060 - 3064

Mitsuru Ohishi, Koichi Yamamoto and Hiromi Rakugi


DOI: 10.2174/1381612811319170013




Chymase Inhibitors

, 19(17): 3065 - 3071

Eiji Yahiro, Shin-ichiro Miura, Satoshi Imaizumi, Yoshinari Uehara and Keijiro Saku


DOI: 10.2174/1381612811319170014




Editorial(Current and Future Options for Lipid-lowering Therapy Beyond Statins)

, 19(17): 3072 - 3073

Ioanna Gouni-Berthold


DOI: 10.2174/1381612811319170015




Omega-3 Fatty Acids: Role in Metabolism and Cardiovascular Disease

, 19(17): 3074 - 3093

Philipp A. Gerber, Ioanna Gouni-Berthold and Kaspar Berneis


DOI: 10.2174/1381612811319170016




The Role of Niacin in Lipid-lowering Treatment: Are we Aiming Too High?

, 19(17): 3094 - 3106

Ioanna Gouni-Berthold and Heiner K. Berthold


DOI: 10.2174/1381612811319170017




Ezetimibe Therapy for Dyslipidemia: An Update

, 19(17): 3107 - 3114

Niki Katsiki, Eleni Theocharidou, Asterios Karagiannis, Vasilios G. Athyros and Dimitri P. Mikhailidis


DOI: 10.2174/13816128113199990314




Colesevelam: A New and Improved Bile Acid Sequestrant?

, 19(17): 3115 - 3123

Konstantinos Tziomalos, Asterios Karagiannis, Dimitri P. Mikhailidis and Vasilios G. Athyros


DOI: 10.2174/1381612811319170019




The Role of Fibrate Treatment in Dyslipidemia: An Overview

, 19(17): 3124 - 3131

Niki Katsiki, Dragana Nikolic, Giuseppe Montalto, Maciej Banach, Dimitri P. Mikhailidis and Manfredi Rizzo


DOI: 10.2174/1381612811319170020




Apolipoprotein B Antisense Inhibition -Update on Mipomersen

, 19(17): 3132 - 3142

Catherine Gebhard, Gabriel Huard, Ekaterini A. Kritikou and Jean-Claude Tardif


DOI: 10.2174/13816128113199990312




The Promise of Cholesteryl Ester Transfer Protein (CETP) Inhibition in the Treatment of Cardiovascular Disease

, 19(17): 3143 - 3149

A.E. Bochem, J.A. Kuivenhoven and E.S.G. Stroes


DOI: 10.2174/1381612811319170022




Mitochondrial Triglyceride Transfer Protein Inhibition: New Achievements in the Treatment of Dyslipidemias

, 19(17): 3150 - 3160

Michael S. Kostapanos, Evangelos C. Rizos, Nikolaos Papanas, Efstratios Maltezos and Moses S. Elisaf


DOI: 10.2174/1381612811319170023




Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibitors in the Treatment of Hypercholesterolemia and other Pathologies

, 19(17): 3161 - 3172

Nabil G. Seidah


DOI: 10.2174/13816128113199990313




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science